Steven Mintz, Director at Serina Therapeutics, Inc. (SER), bought 7,600 shares at $9.50 ($71K) on 2024-06-21, disclosed to the SEC on 2024-06-27.
Open-market purchase of $71k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.50 | 5,000 | $48K | 67.0% |
| 2 | $9.00 | 2,600 | $23K | 33.0% |
| Total | $9.33 avg | 7,600 | $71K | 100% |
| Filing → |
| SER | BUY | 2024-05-23 | $121K | — | Filing → |